Sleep disorders are linked to development of type 2 diabetes and increase the risk of
developing diabetes complications. Treating sleep disorders might therefore play an …

Heart failure (HF) is a common condition with an increasing prevalence. Despite a variety of
evidence-based treatments for patients with HF with reduced ejection fraction, morbidity and …

Obstructive sleep apnea (OSA) is characterized by upper airway collapse during sleep.
Chronic intermittent hypoxia, sleep fragmentation, and inflammatory activation are the main …

Background: Heart failure (HF) patients commonly experience obstructive sleep apnea
(OSA), which may worsen their condition. We reviewed a diverse range of studies to …

Context Excess hepatic and pancreatic fat may contribute to hyperglycemia. Objective The
objective of this study was to examine the effect of dapagliflozin (an SGLT2 inhibitor) on …

The presence of hypertension (HTN) in patients with diabetes mellitus (DM) further worsens
cardiovascular disease (CVD) prognosis. In addition, masked HTN and abnormal circadian …

Obstructive sleep apnea (OSA) is the most common form of sleep-disordered breathing
characterized by intermittent partial or complete closure of the upper airway during sleep. If …

Background Obstructive sleep apnea (OSA) is characterized by hypoxic episodes due to
collapse of the airway during sleep and is frequently associated with obesity, type 2 diabetes …

Purpose The sodium-glucose transporter 2 inhibitor (SGLT2i) empagliflozin may reduce the
incidence of obstructive sleep apnea (OSA) in patients with type 2 diabetes (T2D) and …

Drug-induced myopathy is a well-described clinical entity characterized by muscle damage
leading to symptoms ranging from myalgias to rhabdomyolysis and acute kidney injury …